SlideShare una empresa de Scribd logo
1 de 15
Descargar para leer sin conexión
Good Distribution Practice (GDP)
           Passport Scheme
          for Supply Chain Service Providers To The
        Pharmaceutical, Medical Device and Diagnostics
               Manufacturing Sectors in Ireland


 An initiative of Life Sciences Ireland, a forum within the Irish
Exporters Association which represents Pharmaceutical, Medical
         Device, Biologic and Diagnostic Manufacturers
P a g e |2




CONTENTS
Introduction __________________________________________ 3

Good Distribution Practice Code (GDP) ____________________ 5

  Introduction _________________________________________ 5

  Principle ____________________________________________ 5

  The Manufacturer _____________________________________ 8

  Ports, Airports, Terminal Operators _______________________ 8

  Approved Trainers ____________________________________ 8

  Application for GDP Passport ____________________________ 8

  Inspections __________________________________________ 8

Life Sciences Ireland review _____________________________ 9

  Fact sheet 1: GDP Passport Requirements _________________ 10

  Fact sheet 2: IMB Wholesalers + GDP Passport _____________ 11

  GDP Passport Application ______________________________ 12

Irish Exporters Association Background __________________ 13
P a g e |3




                          Introduction
Ireland is one of the leading international locations for the Life Science industry.
The industry which spans pharmaceuticals, chemicals, diagnostics, medical devices
and biotechnology generates over 50% of our exports making Ireland the largest
net exporter of medicines globally. Ireland is home to 13 of the top 15 companies
in the world and manufactures 9 of the world‘s top 15 medicines. In 2008 there
were over 24,500 people employed in the sector producing exports of over €44
billion. Globally the sector has been expanding by 5-6% per annum since the turn
of the decade, and last year recorded global sales of US $745 billion. By
comparison exports of Life Sciences products from Ireland have more than doubled
in the same time frame and now account for 9% of global sales.

For any Life Science (Pharmaceutical, Medical Device, Biologic and Diagnostic)
manufacturing and supply chain companies, the safe and effective distribution of
their products to the ultimate patient is crucial. This represents a significant
challenge since the Life Science Sector also has to operate in a highly regulated
environment, not least of which is the increasing compliance requirements for an
international temperature controlled supply chain. The industry has indicated that
in the UK over the next 2 to 3 years up to 50% of all newly approved medicines will
be temperature-sensitive biopharmaceutical products.

At the beginning of 2008, the World Health Organisation (WHO) published a
document titled ―Good Distribution Practices (GDP) for Pharmaceutical Products‖ for
commenting on by end of March of this year. This guidance is the counterpart of
the document ―Good Trade and Distribution Practices for Pharmaceutical Starting
Material‖, which was published by the WHO in 2003. At European level, the EU
published its ―Guidelines of Good Distribution Practice of Medicine Products for
Human Use‖ (94/063/3) dating back to 1992.The International Air Transport
Association (IATA) introduced a new set of regulations for airlines and ground
handlers on the 1st July 2009 to counter a pharmaceutical industry report that
suggested that 50% of temperature deviations occur when the consignments are in
the hands of the airlines and their facilities.

All of these international bodies have indicated the need for guidance on a range of
distribution practices for the Life Sciences industry. These can generally be
summarized as laying down requirements for the supply chain service providers to
improve the management of the following:

      Quality systems, organizations and personnel, in the supply chain.
      Premises and storage areas
      Transport vehicles, external packaging and shipping practices
      Temperature controlled transport handling and dispatch areas, as well as
       temperature mappings to verify compliance
      Counterfeit identification
      Exports/imports and sub-supply routings

Life Sciences Ireland was established by the Irish Exporters Association (IEA) two
years ago to address these issues and to develop and deliver training for the
logistics, transport and storage industry; In the process ensuring that the
manufacturers in the sector in Ireland could lead the way by ensuring a regulated,
safe and efficient supply chain system for getting their products delivered to
international markets and the consumer in those markets.
P a g e |4




We wish to thank the input of the Department of Enterprise, Trade and Employment
for its assistance and support through the Accel funding scheme during the early
stages of the training development and pilot delivery. To ensure that the training
and recommended procedures promulgated through these courses were up to the
necessary standards, the IEA carried out an extensive review process with the Life
Sciences manufacturers across Ireland. This resulted in a set of guidelines which
are encapsulated in the GDP Code of Practice which is set out in this publication.

The IEA consulted with the Irish Medicine Board during the process of developing
the GDP Code and welcome their input and support for this Code. We are confident
that the Code and the training practices that go with it, will help to ensure that
Ireland remains the preferred location for Life Sciences companies to develop,
manufacture and distribute their products internationally.




John F Whelan
Chief executive
Irish Exporters Association
P a g e |5




  Good Distribution Practice Code
              (GDP)
 Introduction
This Code of Good Distribution Practice (GDP) arose from the need for all
stakeholders in the Life Science (Pharmaceutical, Medical Device, Biologics and
Diagnostic) industry to work in partnership to ensure supply chain integrity. The
intention is to ensure as far as possible, only bona fide suppliers and customers are
allowed to import, export, and supply and distribute life sciences products in and
out of Ireland. The primary intention is to support the industry and the Competent
and Notified Authorities to guarantee patient safety at all times along complex
global supply chains. Those responsible for ensuring supply chain integrity
(Licensed GMP Manufacturers and Authorised Wholesalers) need to ensure that all
service providers to the life sciences industry understand the fundamentals of a
secure and safe supply chain of medicinal products for human use. By adopting the
Good Distribution Practice (GDP) Code described herein, manufacturers can ensure
that their products arrive with the final customers in perfect condition, as
prescribed for human use. This Code builds on the IEA‘s existing programme to
drive excellence in the supply chain for the Life Science sector in Ireland. The Code
is focused at providing training courses to all levels of personnel involved in the
supply chain. The key to success is the full suite of standardised and certified
training which is to be undertaken by all those engaged either directly by the
manufacturer or indirectly by the Service Provider so that full visibility and
responsibility is clear throughout the entire supply chain.


 Principle
Primary suppliers engaged in transportation and/or warehousing/ logistics of Active
Pharmaceutical Ingredients (API‘s), Finished Pharmaceutical, Medical Devices, and
Diagnostic Products should either obtain;

     A Wholesalers Licence (recently re-named Wholesalers Authorisation ) from
      IMB or
     A Good Distribution Practice (GDP) Passport Licence from Life Sciences
      Ireland

To qualify as a Wholesaler Licence holder a company must satisfy the Irish
Medicines Board‘s (IMB) guidelines on Good Distribution Practice and successfully
pass an inspection.

To become a GDP Passport Licence Holder, the following is required:

   1. The Service Provider must appoint a management representative at each
      distribution point as the in-house GDP Champion who is responsible for
      working closely with manufacturers and an approved GDP Trainer to ensure
      the company meets the requirements of becoming a GDP Passport Holder.
      The GDP Champion has the responsibility of being the key point of contact
      on all compliance and quality aspects on behalf of manufacturers and will
      work to continually improve GDP practices along the supply chain.
P a g e |6




   2. Key personnel involved in the warehousing of medicinal products should
      have the appropriate ability and experience to guarantee that the products
      or materials are properly stored and handled in compliance with the
      manufacturers‘ specifications.

   3. Personnel should be trained in relation to the duties assigned to them and
      the training sessions should be backed up by records.

Premises

   4. Premises (Storage), Equipment (e.g. Transportation) & Processes (Quality
      System in place, security controls) must meet a set of criteria which follows
      the minimum standards set out under the EU Guidelines on GDP or FDA/
      GMP requirements.

   5. Medicinal products should be stored apart from other goods and under the
      conditions specified by the manufacturer, in order to avoid any deterioration
      by light, moisture or temperature.

   6. The storage facilities should be clean, free from litter and dust and pests.

   7. When specific temperature storage conditions are required, storage areas
      should be equipped with temperature recorders that will indicate that the
      required temperature range has been maintained.

   8. Medicinal products with broken seals, damaged packaging or suspected of
      possible contamination should be notified to the Manufacturer, and kept in a
      clearly separated area awaiting the Manufacturers disposal instructions.

Transport and Vehicles

   9. Medicinal and medical device products should be transported in such a
      manner that;
         a. Their identity is not lost
         b. They are not contaminated, and they do not contaminate other
             products or materials.
         c. Adequate precautions are taken against spillage, breakage or theft.
         d. They are secure and not subject to unacceptable degrees of heat,
             cold, light moisture or other adverse influence, or to attack of micro –
             organisms or pests.
         e. Medicinal products requiring controlled temperature storage should
             also be transported by appropriate means.

Procedures and Records

   10. Written procedures should describe the different distribution activities such
       as;
         a. Receipt and checking of deliveries,
         b. Storage, cleaning and maintenance of premises ( including pest
             control)
         c. Recording of storage conditions, security of stock on site and of
             consignments in transit
         d. Withdrawal from stock, records of client orders, returned products,
             recalls etc.
         e. These procedures should be signed and dated by the person assigned
             as the GDP Champion.
P a g e |7




           f. Records should be made each time and operation is undertaken, in
              such a way that all significant activities are traceable.
           g. Records should be clear and readily available.
           h. Records should ensure the traceability of the origin and destination of
              each product.


Training

   11. To become a GDP Passport Licence Holder a Service Provider must be
      capable of demonstrating that all relevant personnel are trained to an
      acceptable level on Good Distribution Practice and that their premises and
      vehicles meet minimum operational/compliance standards. The GDP Licence
      will be valid for 2 years (24 months from date of issue.)

   12. GDP Passport Training has 3 stages
        a. A GDP Champion is nominated (this person is involved at a supervisor
            level) and undertakes the 3 day Intermediate Training Programme
        b. Half day training in GDP is completed by operational staff working in a
            warehousing/ facility.
        c. For transportation drivers a 2 hour training course needs to be
            completed.

   13. All courses include assessment to demonstrate in keeping with regulator
      requirements that learning has taken place.

   14. All participants have to successfully complete a set of questions on the
      training courses provided and all records of the course and assessment form
      part of the individuals training records. Certification is provided for each
      participant who has successfully completed these courses. Certification is
      valid for one year.

   15. Temperature Control Logistics - Where the manufacturer requires
      temperature controls over the transportation or storage of their goods then
      the GDP Passport Holder is required to hold a joint GDP/TCL Passport.

   16.Once a Service Provider meets the requirements set out above (premises,
      training, equipment) they will be issued with a GDP Passport Licence.

   17. Renewal of GDP Licence
         a. Refresher training must be undertaken on a bi-annual basis. This will
            enable Service Providers to get a renewal of their DGP License.

   18. GDP Transport Card

      All of the companies‘ drivers assigned to the collection and delivery of
      Pharmaceutical, Medical Device and Diagnostic Products (PMD & DP) will be
      issued with a valid GDP Transport Card following completion of their
      training. This Card must be produced on arrival at the factory (warehouse)
      gate of the PMD&DP customer.

   19. Service Provider Sub Contractor and third part Service Companies Where a
      Service Provider subcontracts road transport activates, they must ensure
      that all third party drivers hold a GDP Transport Card, otherwise they will
      not be allowed entry to the PMD&DP manufacturers or storage facility to
      deliver or collect products.
P a g e |8




 The Manufacturer

Within the Warehouse/Storage/Logistics areas of manufacturing companies it is
recommended that all personnel handling products must receive GDP training. This
will ensure consistency of GDP standards is in place as products are collected and
moved along the supply chain to final delivery destination. This is necessary to
ensure that the overlap between the standard operating procedures (SOPs) related
to receipt, storage, handling and transportation under GMP guidelines match the
appropriate minimum SOPs for the service providers and that the quality of
transportation fully meets the essential standards of compliance and security and
product integrity as products move along the supply chain.


 Ports, Airports, Terminal Operators

Within the Warehouse/ Storage/ Logistics areas of Airports, Sea Ports, Sea and Air
Terminal operators, it is recommended that all personnel managing their facilities
must receive GDP Training. This is to ensure adequate and consistent availability of
facilities to handle medicinal products which are handled, stored, or transit these
areas.


 Approved Trainers

The Life Sciences Ireland Steering Committee has approved a number of Trainers to
carry out the training requirements of the GDP Licence / Passport system. Only
companies approved by the Life Sciences Ireland Steering committee may be
engaged to conduct the training. The approved trainers are also certified by
Institute of International Trade of Ireland (IITI).

All training providers will be obliged to ensure that the training content meets the
guidelines as set out by the IMB/EU/FDA and World Health Organisation (WHO)
minimum requirements for companies to remain compliant under their
manufacturing or wholesale authorisation licence in relation to the handling,
storage and transportation of Medical Device, Pharmaceutical or Diagnostic
products.


 Application for GDP Passport

Firms wishing to become GDP Passport holders are invited to submit their
applications to the Director, Life Sciences Ireland, Irish Exporters Association, 28
Merrion Sq, Dublin 2, Tel: 01 6612182, Fax: 01 6612315 Email:
lifesciences@irishexporters.org


 Inspections

Inspections of facilities will be based on records of prior inspections carried out by
IMB, or the Manufacturers and /or by an approved Life Sciences Ireland inspector.
Each Service Provider will be requested to supply evidence of any inspections
carried out on their facilities over the past 2 years by any authorised bodies, as part
of the process of GDP Licence application.
P a g e |9




      Life Sciences Ireland Review
Life Sciences Ireland is an industry grouping within the Irish Exporters Association.
The broad focus of the grouping is to support multinational and indigenous life
sciences companies in their international trade and supply chain activities and to
preserve the sector‘s status as Ireland‘s fastest growing export grouping.

Specifically, the Life Sciences Ireland grouping is focused on driving export
excellence in life sciences by supporting the following critical business areas:

   1. Good Distribution Practices – Benchmarking the standard for the industry
      and promoting its use by all service providers nationally and internationally.
   2. Logistical Efficiency - promoting and providing access to the latest cost
      reduction and supply chain efficiency improvement techniques and
      opportunities.
   3. Material Quality Control – assisting life sciences companies and those
      serving the industry to keep up to speed in the latest material handling and
      environmental control methods and standards.
   4. Regulatory Response – providing training and support to enhance the
      sector‘s ‗rapid response‘ capability to changing regulations and standards.
   5. Good manufacturing Practice – supporting companies achieve and
      maintain their GMP standards in line with IMB and international regulatory
      body requirements.
   6. Lobbying - ensuring that companies within the sector in Ireland have the
      opportunity to have their views represented at WHO, EU and national
      government to ensure any new or proposed changes to legislation are
      efficiently processed.


For more information contact; The Director, Life Science Division at;

28 Merrion Square, Dublin 2, Ireland.

Phone; +353-1 6612182;     e-mail: lifesciences@irishexporters.org

www.irishexporters.ie/lifesciences.shtml
P a g e | 10




 Fact sheet 1: GDP Passport Requirements

A Code of Practice – Good Distribution Practice (GDP) for Logistics Service Providers
(Transportation, Warehousing and Storage) has been drawn up and approved by
the Pharmaceutical Manufacturing & Medical Device Sectors This Code of Good
Distribution Practice (GDP) arose from the need for all stakeholders in the Life
Science Industry (pharmaceutical, medical device, biologics and diagnostics) to
work in partnership to ensure supply chain integrity. The intention is to ensure as
far as possible, only bona fide suppliers and customers are allowed to import,
export, supply, and distribute life sciences products in and out of Ireland. The
primary intention is to support the industry and the authorised authorities to
guarantee patient safety at all times along complex global supply chains. Those
responsible for ensuring supply chain integrity (manufacturers and wholesalers)
need to ensure that all service providers to the life sciences industry clearly
understand the fundamentals of a secure and safe supply chain of medicinal and
medical device products for human use. By adopting the Good Distribution Practice
(GDP) Code manufacturers can ensure that their products arrive with the final
customers in perfect condition, as prescribed for human use.

What is required to gain GDP Passport Accreditation ?

   o   Appointment of GDP Champion – must have completed an intensive 3 Day
       GDP Training Module
   o   All relevant Warehouse Staff completed 1 day GDP Introduction Program
   o   All Drivers involved in Transportation & Handling of Pharmaceutical Products
       must complete 2 Hour Driver Training
   o   All training must be given by Certified Institute of International Trade of
       Ireland IITI (training body of Irish Exporters Association IEA) Trainer
   o   Code, the facility to review Service Providers training records.
   o   Drivers will receive a GDP Card valid for two years.
   o   Manufacturers will require Drivers to produce their GDP Card on arrival at
       the Factory Gate.
   o   Each location / branch needs to have an appointed GDP Passport Champion
       and undergo premises inspection or can demonstrate that their premises
       meet the required Life Science Standards.
   o   Formal Certificate of Accreditation will be presented by IEA
   o   Passport is valid for two years and renewal will require refresher training.

The Code of Practice was developed in consultation with the Irish Medicines Board
(IMB) and all training is designed to meet the training requirements as set out in
the IMB‘s GDP Guidelines ~ Wholesaler Authorisation. All Training is accredited by
the Institute of International Trade of Ireland (IITI).

For information of the above please contact ;
The Director , Life Sciences Director
28Merrion Square, Dublin 2. ----Email: lifesciences@irishexporters.org
Phone: +353-1 6612182
P a g e | 11




 Fact sheet 2: IMB Wholesalers + GDP Passport

IMB Authorised Wholesalers who wish to apply for GDP Passport must proceed as
follows:

1. Formal letter of application plus GDP Passport Application Form

2. Receive auditor from Life Sciences Ireland who will:
         a) Inspect IMB Wholesalers licence and record reference number and
            validity dates.
         b) All GDP training records including driver training.

3. The Life Sciences Auditor will send back report on a) and b) above and a
   recommendation as to whether to issue GDP Passport, and which drivers to be
   covered by the GDP Driver Card

4. The IMB Wholesaler will then be issued with an invoice for the work carried out
   above.

5. Finally the IMB Wholesaler will be issued with a GDP Passport and Driver GDP
   Card.
P a g e | 12




 GDP Passport Application


We wish to apply for a GDP Passport. Please find below the information needed in
order to start the process to obtain the GDP Passport:

Attn; The Director, Life Sciences Ireland, 28 Merrion Square, Dublin 2

e-mail: lifesciences@irishexporters.org

Phone: +353-1 6612182

I wish to apply for a GDP Passport, please advise me of the process.

My contact details are;


 Company Name:

 Contact Person:

 Job Title:

 Phone Number:

 Fax Number:

 Address:
  E-mail
  Phone Number:
                  :


Signature:




Signed By:

Date:
P a g e | 13




        Irish Exporters Association
                Background
The Irish Exporters Association, was incorporated in May 1951, has a buoyant
membership base and is actively engaged in promoting the best conditions for
exporting companies in Ireland. Our membership is comprised of exporters of
merchandise, services and export service providers from all sectors of Irish
business, multi-nationals and indigenous SMEs.

Overview of IEA Membership Benefits:
    Provides a Voice to all those in Export Industry
    Represent members‘ interest at the highest level
    Key Networking Opportunities
    Expert Assistance on International Trade matters
    Frequent Publications on Export issues
    Regular Ezines on latest National and International Developments
    Free/ Discounted Export Training Programmes
    Discounted Services to Members
    Notification of Business Opportunities
    Visa / Export Documentation Legalisation
    Brand audits and clinics
    Export Direct out sourcing support Services
    Export Market Development Programmes
    Channel Development Clinics
P a g e | 14




The IEA offers tailored assistance and support to each company who applies for
membership. Tailored services include;

      Market Entry Strategy—we assist companies to devise their best market
       entry strategy for their chosen markets.
      Channel Strategy—focused programmes are available to assist companies
       use best practice in managing the process to getting listed, and building
       business in new Channels.
      Full Marketing Cycle –we offered funded programmes to enable companies
       to review their full marketing cycle, identify gaps in the capabilities and put
       mentors/ consultants working with the business to address the gaps, and
       expand business.
      Logistical Efficiency – we promote and provide access to the latest cost
       reduction and supply chain efficiency improvement techniques and
       opportunities.
      Material Quality Control – we assist food & drink companies and those
       serving the industry to keep up to speed in the latest material handling and
       environmental control methods and standards.
      Good Distribution Practices – Benchmarking the standard for the industry
       and promoting its use by all service providers regionally and internationally.
      Regulatory Response – we provide training and support to enhance the
       sector‘s ‗rapid response‘ capability to changing regulations and standards.

For more information you can visit www.irishexporters.ie or call us on +353-1
6612182

If you wish you can also send us an email to iea@irishexporters.ie
Driving Export Excellence in Life Sciences Industry




A division of the Irish exporters Association

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
How can I get Ayurvedic drug manufacturing license?
How can I  get Ayurvedic drug manufacturing license?How can I  get Ayurvedic drug manufacturing license?
How can I get Ayurvedic drug manufacturing license?
 
NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptx
 
Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201
 
Otc drugs
Otc drugsOtc drugs
Otc drugs
 
Dossier Management and Regulatory Affairs.
Dossier Management and Regulatory Affairs.Dossier Management and Regulatory Affairs.
Dossier Management and Regulatory Affairs.
 
A Detailed Study on Pharmaceutical Drug Recall
A Detailed Study on Pharmaceutical Drug RecallA Detailed Study on Pharmaceutical Drug Recall
A Detailed Study on Pharmaceutical Drug Recall
 
Pharmacy “it’s even more than you can imagine.”
Pharmacy “it’s even more than you can imagine.”Pharmacy “it’s even more than you can imagine.”
Pharmacy “it’s even more than you can imagine.”
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairs
 
RCPA by GIRISH
RCPA by GIRISHRCPA by GIRISH
RCPA by GIRISH
 
Pharmaceutical Sales Skills
Pharmaceutical Sales SkillsPharmaceutical Sales Skills
Pharmaceutical Sales Skills
 
NDA- New Drug Application
NDA- New Drug ApplicationNDA- New Drug Application
NDA- New Drug Application
 
Usfda ppn
Usfda ppnUsfda ppn
Usfda ppn
 
Legality of prescription..pptx
Legality of prescription..pptxLegality of prescription..pptx
Legality of prescription..pptx
 
Role of Medical Representative | Pharmaadda
 Role of Medical Representative | Pharmaadda Role of Medical Representative | Pharmaadda
Role of Medical Representative | Pharmaadda
 
OTC DRUGS (OVER THE COUNTER)
OTC DRUGS (OVER THE COUNTER)OTC DRUGS (OVER THE COUNTER)
OTC DRUGS (OVER THE COUNTER)
 
Retail Chemist Prescription Audit / RCPA --- Pharma
Retail Chemist Prescription Audit / RCPA --- Pharma Retail Chemist Prescription Audit / RCPA --- Pharma
Retail Chemist Prescription Audit / RCPA --- Pharma
 
Fda med watch
Fda med watchFda med watch
Fda med watch
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
 
Job of Medical representative
Job of Medical representativeJob of Medical representative
Job of Medical representative
 

Destacado

MTS LogiMed Presentation 2016 r2
MTS LogiMed Presentation 2016 r2MTS LogiMed Presentation 2016 r2
MTS LogiMed Presentation 2016 r2
Stephen Bradley
 
Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016
Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016
Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016
Lora Cecere
 
Supply Chain Management in healthcare
Supply Chain Management  in healthcareSupply Chain Management  in healthcare
Supply Chain Management in healthcare
Anurag Gupta
 

Destacado (11)

UDI: What & How within the overall Medical Device value chain
UDI: What & How within the overall Medical Device value chainUDI: What & How within the overall Medical Device value chain
UDI: What & How within the overall Medical Device value chain
 
Loftware UDI Webinar 1
Loftware UDI Webinar 1Loftware UDI Webinar 1
Loftware UDI Webinar 1
 
The Role of Technology in Cardiovascular Health Care Cost Growth 4.21.10
The Role of Technology in Cardiovascular Health Care Cost Growth 4.21.10The Role of Technology in Cardiovascular Health Care Cost Growth 4.21.10
The Role of Technology in Cardiovascular Health Care Cost Growth 4.21.10
 
Best Practices in Supply Chain Management: SharePoint
Best Practices in Supply Chain Management: SharePointBest Practices in Supply Chain Management: SharePoint
Best Practices in Supply Chain Management: SharePoint
 
MTS LogiMed Presentation 2016 r2
MTS LogiMed Presentation 2016 r2MTS LogiMed Presentation 2016 r2
MTS LogiMed Presentation 2016 r2
 
Supply chain risk management
Supply chain risk managementSupply chain risk management
Supply chain risk management
 
Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016
Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016
Supply Chain Metrics That Matter: A Focus on Medical Device Companies – 2016
 
2015 trends in global medical device strategy and issues for the supply chain...
2015 trends in global medical device strategy and issues for the supply chain...2015 trends in global medical device strategy and issues for the supply chain...
2015 trends in global medical device strategy and issues for the supply chain...
 
Medical device Industry 2015
Medical device Industry 2015Medical device Industry 2015
Medical device Industry 2015
 
Logimed may7
Logimed may7Logimed may7
Logimed may7
 
Supply Chain Management in healthcare
Supply Chain Management  in healthcareSupply Chain Management  in healthcare
Supply Chain Management in healthcare
 

Similar a Gdp Code Of Practice & Passport Scheme

Molecules Make a Difference
Molecules Make a DifferenceMolecules Make a Difference
Molecules Make a Difference
Sophie Moran
 
Clandestines and food contamination presentation - Autumn 2015
Clandestines and food contamination presentation - Autumn 2015Clandestines and food contamination presentation - Autumn 2015
Clandestines and food contamination presentation - Autumn 2015
Alex Schofield
 
Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1
nordion1
 

Similar a Gdp Code Of Practice & Passport Scheme (20)

The Strategic for Formation of Inter Organizational Network towards Global Ma...
The Strategic for Formation of Inter Organizational Network towards Global Ma...The Strategic for Formation of Inter Organizational Network towards Global Ma...
The Strategic for Formation of Inter Organizational Network towards Global Ma...
 
Food Safety Standards and Certifications.pptx
Food Safety Standards and  Certifications.pptxFood Safety Standards and  Certifications.pptx
Food Safety Standards and Certifications.pptx
 
Food Safety Standards and Certifications.pptx
Food Safety Standards and  Certifications.pptxFood Safety Standards and  Certifications.pptx
Food Safety Standards and Certifications.pptx
 
Molecules Make a Difference
Molecules Make a DifferenceMolecules Make a Difference
Molecules Make a Difference
 
BRITISH RETAIL CONSORTIUM
BRITISH RETAIL CONSORTIUM BRITISH RETAIL CONSORTIUM
BRITISH RETAIL CONSORTIUM
 
BioKinetic Profile.docx
BioKinetic Profile.docxBioKinetic Profile.docx
BioKinetic Profile.docx
 
Clandestines and food contamination presentation - Autumn 2015
Clandestines and food contamination presentation - Autumn 2015Clandestines and food contamination presentation - Autumn 2015
Clandestines and food contamination presentation - Autumn 2015
 
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh
"Where Agri Meets Tech,  Driving Research to Market" Ultan O’Raghallaigh "Where Agri Meets Tech,  Driving Research to Market" Ultan O’Raghallaigh
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh
 
The Concept of HalalGAP as a Means of Gaining Unfair Competitive Advantage
The Concept of HalalGAP as a Means of Gaining Unfair Competitive AdvantageThe Concept of HalalGAP as a Means of Gaining Unfair Competitive Advantage
The Concept of HalalGAP as a Means of Gaining Unfair Competitive Advantage
 
The Concept of HalalGAP as a Means of Gaining Unfair
The Concept of HalalGAP as a Means of Gaining Unfair The Concept of HalalGAP as a Means of Gaining Unfair
The Concept of HalalGAP as a Means of Gaining Unfair
 
Food safety standards and certifications
Food safety standards and certificationsFood safety standards and certifications
Food safety standards and certifications
 
Richard siwes report
Richard siwes reportRichard siwes report
Richard siwes report
 
Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1Nordion corporate presentation_2014_q1
Nordion corporate presentation_2014_q1
 
Traceability in the food chain
Traceability in the food chainTraceability in the food chain
Traceability in the food chain
 
Presentation 4 (4).pptx
Presentation 4 (4).pptxPresentation 4 (4).pptx
Presentation 4 (4).pptx
 
Presentation 4 (4).pptx
Presentation 4 (4).pptxPresentation 4 (4).pptx
Presentation 4 (4).pptx
 
ICH-GCP.pptx
ICH-GCP.pptxICH-GCP.pptx
ICH-GCP.pptx
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
 
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
 
Analysis of the Determinants of Fish Quality in Export Markets
Analysis of the Determinants of Fish Quality in Export MarketsAnalysis of the Determinants of Fish Quality in Export Markets
Analysis of the Determinants of Fish Quality in Export Markets
 

Gdp Code Of Practice & Passport Scheme

  • 1. Good Distribution Practice (GDP) Passport Scheme for Supply Chain Service Providers To The Pharmaceutical, Medical Device and Diagnostics Manufacturing Sectors in Ireland An initiative of Life Sciences Ireland, a forum within the Irish Exporters Association which represents Pharmaceutical, Medical Device, Biologic and Diagnostic Manufacturers
  • 2. P a g e |2 CONTENTS Introduction __________________________________________ 3 Good Distribution Practice Code (GDP) ____________________ 5 Introduction _________________________________________ 5 Principle ____________________________________________ 5 The Manufacturer _____________________________________ 8 Ports, Airports, Terminal Operators _______________________ 8 Approved Trainers ____________________________________ 8 Application for GDP Passport ____________________________ 8 Inspections __________________________________________ 8 Life Sciences Ireland review _____________________________ 9 Fact sheet 1: GDP Passport Requirements _________________ 10 Fact sheet 2: IMB Wholesalers + GDP Passport _____________ 11 GDP Passport Application ______________________________ 12 Irish Exporters Association Background __________________ 13
  • 3. P a g e |3 Introduction Ireland is one of the leading international locations for the Life Science industry. The industry which spans pharmaceuticals, chemicals, diagnostics, medical devices and biotechnology generates over 50% of our exports making Ireland the largest net exporter of medicines globally. Ireland is home to 13 of the top 15 companies in the world and manufactures 9 of the world‘s top 15 medicines. In 2008 there were over 24,500 people employed in the sector producing exports of over €44 billion. Globally the sector has been expanding by 5-6% per annum since the turn of the decade, and last year recorded global sales of US $745 billion. By comparison exports of Life Sciences products from Ireland have more than doubled in the same time frame and now account for 9% of global sales. For any Life Science (Pharmaceutical, Medical Device, Biologic and Diagnostic) manufacturing and supply chain companies, the safe and effective distribution of their products to the ultimate patient is crucial. This represents a significant challenge since the Life Science Sector also has to operate in a highly regulated environment, not least of which is the increasing compliance requirements for an international temperature controlled supply chain. The industry has indicated that in the UK over the next 2 to 3 years up to 50% of all newly approved medicines will be temperature-sensitive biopharmaceutical products. At the beginning of 2008, the World Health Organisation (WHO) published a document titled ―Good Distribution Practices (GDP) for Pharmaceutical Products‖ for commenting on by end of March of this year. This guidance is the counterpart of the document ―Good Trade and Distribution Practices for Pharmaceutical Starting Material‖, which was published by the WHO in 2003. At European level, the EU published its ―Guidelines of Good Distribution Practice of Medicine Products for Human Use‖ (94/063/3) dating back to 1992.The International Air Transport Association (IATA) introduced a new set of regulations for airlines and ground handlers on the 1st July 2009 to counter a pharmaceutical industry report that suggested that 50% of temperature deviations occur when the consignments are in the hands of the airlines and their facilities. All of these international bodies have indicated the need for guidance on a range of distribution practices for the Life Sciences industry. These can generally be summarized as laying down requirements for the supply chain service providers to improve the management of the following:  Quality systems, organizations and personnel, in the supply chain.  Premises and storage areas  Transport vehicles, external packaging and shipping practices  Temperature controlled transport handling and dispatch areas, as well as temperature mappings to verify compliance  Counterfeit identification  Exports/imports and sub-supply routings Life Sciences Ireland was established by the Irish Exporters Association (IEA) two years ago to address these issues and to develop and deliver training for the logistics, transport and storage industry; In the process ensuring that the manufacturers in the sector in Ireland could lead the way by ensuring a regulated, safe and efficient supply chain system for getting their products delivered to international markets and the consumer in those markets.
  • 4. P a g e |4 We wish to thank the input of the Department of Enterprise, Trade and Employment for its assistance and support through the Accel funding scheme during the early stages of the training development and pilot delivery. To ensure that the training and recommended procedures promulgated through these courses were up to the necessary standards, the IEA carried out an extensive review process with the Life Sciences manufacturers across Ireland. This resulted in a set of guidelines which are encapsulated in the GDP Code of Practice which is set out in this publication. The IEA consulted with the Irish Medicine Board during the process of developing the GDP Code and welcome their input and support for this Code. We are confident that the Code and the training practices that go with it, will help to ensure that Ireland remains the preferred location for Life Sciences companies to develop, manufacture and distribute their products internationally. John F Whelan Chief executive Irish Exporters Association
  • 5. P a g e |5 Good Distribution Practice Code (GDP) Introduction This Code of Good Distribution Practice (GDP) arose from the need for all stakeholders in the Life Science (Pharmaceutical, Medical Device, Biologics and Diagnostic) industry to work in partnership to ensure supply chain integrity. The intention is to ensure as far as possible, only bona fide suppliers and customers are allowed to import, export, and supply and distribute life sciences products in and out of Ireland. The primary intention is to support the industry and the Competent and Notified Authorities to guarantee patient safety at all times along complex global supply chains. Those responsible for ensuring supply chain integrity (Licensed GMP Manufacturers and Authorised Wholesalers) need to ensure that all service providers to the life sciences industry understand the fundamentals of a secure and safe supply chain of medicinal products for human use. By adopting the Good Distribution Practice (GDP) Code described herein, manufacturers can ensure that their products arrive with the final customers in perfect condition, as prescribed for human use. This Code builds on the IEA‘s existing programme to drive excellence in the supply chain for the Life Science sector in Ireland. The Code is focused at providing training courses to all levels of personnel involved in the supply chain. The key to success is the full suite of standardised and certified training which is to be undertaken by all those engaged either directly by the manufacturer or indirectly by the Service Provider so that full visibility and responsibility is clear throughout the entire supply chain. Principle Primary suppliers engaged in transportation and/or warehousing/ logistics of Active Pharmaceutical Ingredients (API‘s), Finished Pharmaceutical, Medical Devices, and Diagnostic Products should either obtain;  A Wholesalers Licence (recently re-named Wholesalers Authorisation ) from IMB or  A Good Distribution Practice (GDP) Passport Licence from Life Sciences Ireland To qualify as a Wholesaler Licence holder a company must satisfy the Irish Medicines Board‘s (IMB) guidelines on Good Distribution Practice and successfully pass an inspection. To become a GDP Passport Licence Holder, the following is required: 1. The Service Provider must appoint a management representative at each distribution point as the in-house GDP Champion who is responsible for working closely with manufacturers and an approved GDP Trainer to ensure the company meets the requirements of becoming a GDP Passport Holder. The GDP Champion has the responsibility of being the key point of contact on all compliance and quality aspects on behalf of manufacturers and will work to continually improve GDP practices along the supply chain.
  • 6. P a g e |6 2. Key personnel involved in the warehousing of medicinal products should have the appropriate ability and experience to guarantee that the products or materials are properly stored and handled in compliance with the manufacturers‘ specifications. 3. Personnel should be trained in relation to the duties assigned to them and the training sessions should be backed up by records. Premises 4. Premises (Storage), Equipment (e.g. Transportation) & Processes (Quality System in place, security controls) must meet a set of criteria which follows the minimum standards set out under the EU Guidelines on GDP or FDA/ GMP requirements. 5. Medicinal products should be stored apart from other goods and under the conditions specified by the manufacturer, in order to avoid any deterioration by light, moisture or temperature. 6. The storage facilities should be clean, free from litter and dust and pests. 7. When specific temperature storage conditions are required, storage areas should be equipped with temperature recorders that will indicate that the required temperature range has been maintained. 8. Medicinal products with broken seals, damaged packaging or suspected of possible contamination should be notified to the Manufacturer, and kept in a clearly separated area awaiting the Manufacturers disposal instructions. Transport and Vehicles 9. Medicinal and medical device products should be transported in such a manner that; a. Their identity is not lost b. They are not contaminated, and they do not contaminate other products or materials. c. Adequate precautions are taken against spillage, breakage or theft. d. They are secure and not subject to unacceptable degrees of heat, cold, light moisture or other adverse influence, or to attack of micro – organisms or pests. e. Medicinal products requiring controlled temperature storage should also be transported by appropriate means. Procedures and Records 10. Written procedures should describe the different distribution activities such as; a. Receipt and checking of deliveries, b. Storage, cleaning and maintenance of premises ( including pest control) c. Recording of storage conditions, security of stock on site and of consignments in transit d. Withdrawal from stock, records of client orders, returned products, recalls etc. e. These procedures should be signed and dated by the person assigned as the GDP Champion.
  • 7. P a g e |7 f. Records should be made each time and operation is undertaken, in such a way that all significant activities are traceable. g. Records should be clear and readily available. h. Records should ensure the traceability of the origin and destination of each product. Training 11. To become a GDP Passport Licence Holder a Service Provider must be capable of demonstrating that all relevant personnel are trained to an acceptable level on Good Distribution Practice and that their premises and vehicles meet minimum operational/compliance standards. The GDP Licence will be valid for 2 years (24 months from date of issue.) 12. GDP Passport Training has 3 stages a. A GDP Champion is nominated (this person is involved at a supervisor level) and undertakes the 3 day Intermediate Training Programme b. Half day training in GDP is completed by operational staff working in a warehousing/ facility. c. For transportation drivers a 2 hour training course needs to be completed. 13. All courses include assessment to demonstrate in keeping with regulator requirements that learning has taken place. 14. All participants have to successfully complete a set of questions on the training courses provided and all records of the course and assessment form part of the individuals training records. Certification is provided for each participant who has successfully completed these courses. Certification is valid for one year. 15. Temperature Control Logistics - Where the manufacturer requires temperature controls over the transportation or storage of their goods then the GDP Passport Holder is required to hold a joint GDP/TCL Passport. 16.Once a Service Provider meets the requirements set out above (premises, training, equipment) they will be issued with a GDP Passport Licence. 17. Renewal of GDP Licence a. Refresher training must be undertaken on a bi-annual basis. This will enable Service Providers to get a renewal of their DGP License. 18. GDP Transport Card All of the companies‘ drivers assigned to the collection and delivery of Pharmaceutical, Medical Device and Diagnostic Products (PMD & DP) will be issued with a valid GDP Transport Card following completion of their training. This Card must be produced on arrival at the factory (warehouse) gate of the PMD&DP customer. 19. Service Provider Sub Contractor and third part Service Companies Where a Service Provider subcontracts road transport activates, they must ensure that all third party drivers hold a GDP Transport Card, otherwise they will not be allowed entry to the PMD&DP manufacturers or storage facility to deliver or collect products.
  • 8. P a g e |8 The Manufacturer Within the Warehouse/Storage/Logistics areas of manufacturing companies it is recommended that all personnel handling products must receive GDP training. This will ensure consistency of GDP standards is in place as products are collected and moved along the supply chain to final delivery destination. This is necessary to ensure that the overlap between the standard operating procedures (SOPs) related to receipt, storage, handling and transportation under GMP guidelines match the appropriate minimum SOPs for the service providers and that the quality of transportation fully meets the essential standards of compliance and security and product integrity as products move along the supply chain. Ports, Airports, Terminal Operators Within the Warehouse/ Storage/ Logistics areas of Airports, Sea Ports, Sea and Air Terminal operators, it is recommended that all personnel managing their facilities must receive GDP Training. This is to ensure adequate and consistent availability of facilities to handle medicinal products which are handled, stored, or transit these areas. Approved Trainers The Life Sciences Ireland Steering Committee has approved a number of Trainers to carry out the training requirements of the GDP Licence / Passport system. Only companies approved by the Life Sciences Ireland Steering committee may be engaged to conduct the training. The approved trainers are also certified by Institute of International Trade of Ireland (IITI). All training providers will be obliged to ensure that the training content meets the guidelines as set out by the IMB/EU/FDA and World Health Organisation (WHO) minimum requirements for companies to remain compliant under their manufacturing or wholesale authorisation licence in relation to the handling, storage and transportation of Medical Device, Pharmaceutical or Diagnostic products. Application for GDP Passport Firms wishing to become GDP Passport holders are invited to submit their applications to the Director, Life Sciences Ireland, Irish Exporters Association, 28 Merrion Sq, Dublin 2, Tel: 01 6612182, Fax: 01 6612315 Email: lifesciences@irishexporters.org Inspections Inspections of facilities will be based on records of prior inspections carried out by IMB, or the Manufacturers and /or by an approved Life Sciences Ireland inspector. Each Service Provider will be requested to supply evidence of any inspections carried out on their facilities over the past 2 years by any authorised bodies, as part of the process of GDP Licence application.
  • 9. P a g e |9 Life Sciences Ireland Review Life Sciences Ireland is an industry grouping within the Irish Exporters Association. The broad focus of the grouping is to support multinational and indigenous life sciences companies in their international trade and supply chain activities and to preserve the sector‘s status as Ireland‘s fastest growing export grouping. Specifically, the Life Sciences Ireland grouping is focused on driving export excellence in life sciences by supporting the following critical business areas: 1. Good Distribution Practices – Benchmarking the standard for the industry and promoting its use by all service providers nationally and internationally. 2. Logistical Efficiency - promoting and providing access to the latest cost reduction and supply chain efficiency improvement techniques and opportunities. 3. Material Quality Control – assisting life sciences companies and those serving the industry to keep up to speed in the latest material handling and environmental control methods and standards. 4. Regulatory Response – providing training and support to enhance the sector‘s ‗rapid response‘ capability to changing regulations and standards. 5. Good manufacturing Practice – supporting companies achieve and maintain their GMP standards in line with IMB and international regulatory body requirements. 6. Lobbying - ensuring that companies within the sector in Ireland have the opportunity to have their views represented at WHO, EU and national government to ensure any new or proposed changes to legislation are efficiently processed. For more information contact; The Director, Life Science Division at; 28 Merrion Square, Dublin 2, Ireland. Phone; +353-1 6612182; e-mail: lifesciences@irishexporters.org www.irishexporters.ie/lifesciences.shtml
  • 10. P a g e | 10 Fact sheet 1: GDP Passport Requirements A Code of Practice – Good Distribution Practice (GDP) for Logistics Service Providers (Transportation, Warehousing and Storage) has been drawn up and approved by the Pharmaceutical Manufacturing & Medical Device Sectors This Code of Good Distribution Practice (GDP) arose from the need for all stakeholders in the Life Science Industry (pharmaceutical, medical device, biologics and diagnostics) to work in partnership to ensure supply chain integrity. The intention is to ensure as far as possible, only bona fide suppliers and customers are allowed to import, export, supply, and distribute life sciences products in and out of Ireland. The primary intention is to support the industry and the authorised authorities to guarantee patient safety at all times along complex global supply chains. Those responsible for ensuring supply chain integrity (manufacturers and wholesalers) need to ensure that all service providers to the life sciences industry clearly understand the fundamentals of a secure and safe supply chain of medicinal and medical device products for human use. By adopting the Good Distribution Practice (GDP) Code manufacturers can ensure that their products arrive with the final customers in perfect condition, as prescribed for human use. What is required to gain GDP Passport Accreditation ? o Appointment of GDP Champion – must have completed an intensive 3 Day GDP Training Module o All relevant Warehouse Staff completed 1 day GDP Introduction Program o All Drivers involved in Transportation & Handling of Pharmaceutical Products must complete 2 Hour Driver Training o All training must be given by Certified Institute of International Trade of Ireland IITI (training body of Irish Exporters Association IEA) Trainer o Code, the facility to review Service Providers training records. o Drivers will receive a GDP Card valid for two years. o Manufacturers will require Drivers to produce their GDP Card on arrival at the Factory Gate. o Each location / branch needs to have an appointed GDP Passport Champion and undergo premises inspection or can demonstrate that their premises meet the required Life Science Standards. o Formal Certificate of Accreditation will be presented by IEA o Passport is valid for two years and renewal will require refresher training. The Code of Practice was developed in consultation with the Irish Medicines Board (IMB) and all training is designed to meet the training requirements as set out in the IMB‘s GDP Guidelines ~ Wholesaler Authorisation. All Training is accredited by the Institute of International Trade of Ireland (IITI). For information of the above please contact ; The Director , Life Sciences Director 28Merrion Square, Dublin 2. ----Email: lifesciences@irishexporters.org Phone: +353-1 6612182
  • 11. P a g e | 11 Fact sheet 2: IMB Wholesalers + GDP Passport IMB Authorised Wholesalers who wish to apply for GDP Passport must proceed as follows: 1. Formal letter of application plus GDP Passport Application Form 2. Receive auditor from Life Sciences Ireland who will: a) Inspect IMB Wholesalers licence and record reference number and validity dates. b) All GDP training records including driver training. 3. The Life Sciences Auditor will send back report on a) and b) above and a recommendation as to whether to issue GDP Passport, and which drivers to be covered by the GDP Driver Card 4. The IMB Wholesaler will then be issued with an invoice for the work carried out above. 5. Finally the IMB Wholesaler will be issued with a GDP Passport and Driver GDP Card.
  • 12. P a g e | 12 GDP Passport Application We wish to apply for a GDP Passport. Please find below the information needed in order to start the process to obtain the GDP Passport: Attn; The Director, Life Sciences Ireland, 28 Merrion Square, Dublin 2 e-mail: lifesciences@irishexporters.org Phone: +353-1 6612182 I wish to apply for a GDP Passport, please advise me of the process. My contact details are; Company Name: Contact Person: Job Title: Phone Number: Fax Number: Address: E-mail Phone Number: : Signature: Signed By: Date:
  • 13. P a g e | 13 Irish Exporters Association Background The Irish Exporters Association, was incorporated in May 1951, has a buoyant membership base and is actively engaged in promoting the best conditions for exporting companies in Ireland. Our membership is comprised of exporters of merchandise, services and export service providers from all sectors of Irish business, multi-nationals and indigenous SMEs. Overview of IEA Membership Benefits:  Provides a Voice to all those in Export Industry  Represent members‘ interest at the highest level  Key Networking Opportunities  Expert Assistance on International Trade matters  Frequent Publications on Export issues  Regular Ezines on latest National and International Developments  Free/ Discounted Export Training Programmes  Discounted Services to Members  Notification of Business Opportunities  Visa / Export Documentation Legalisation  Brand audits and clinics  Export Direct out sourcing support Services  Export Market Development Programmes  Channel Development Clinics
  • 14. P a g e | 14 The IEA offers tailored assistance and support to each company who applies for membership. Tailored services include;  Market Entry Strategy—we assist companies to devise their best market entry strategy for their chosen markets.  Channel Strategy—focused programmes are available to assist companies use best practice in managing the process to getting listed, and building business in new Channels.  Full Marketing Cycle –we offered funded programmes to enable companies to review their full marketing cycle, identify gaps in the capabilities and put mentors/ consultants working with the business to address the gaps, and expand business.  Logistical Efficiency – we promote and provide access to the latest cost reduction and supply chain efficiency improvement techniques and opportunities.  Material Quality Control – we assist food & drink companies and those serving the industry to keep up to speed in the latest material handling and environmental control methods and standards.  Good Distribution Practices – Benchmarking the standard for the industry and promoting its use by all service providers regionally and internationally.  Regulatory Response – we provide training and support to enhance the sector‘s ‗rapid response‘ capability to changing regulations and standards. For more information you can visit www.irishexporters.ie or call us on +353-1 6612182 If you wish you can also send us an email to iea@irishexporters.ie
  • 15. Driving Export Excellence in Life Sciences Industry A division of the Irish exporters Association